Clinical Trial

E-Detection Tool for Emerging Mental Disorders

Study acronym: ENTER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Psychosis is a severe mental disorder that involves abnormal experiences and altered behaviour. Although the onset of psychosis occurs in young people, most cases will only be identified later in the course of illness. The delayed detection is the main cause of significant negative long-term outcomes. The current proposal will develop an innovative E-mental health detection tool to effectively improve the identification of young people with emerging psychosis. This tool will be implemented on digital platforms including websites, tablets and mobile phones. Young people will be asked to complete an online questionnaire and two short online-exercises and will then be invited for face-to-face assessments to further confirm whether they are experiencing an emerging psychosis. This digital approach leverages previous expertise by the research team and it is expected to provide novel avenues to enable the identification of young people with emerging psychosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-11-09; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2023-03-07
Trial Details
NCT Number NCT05127278
Lead Sponsor King's College London
Collaborators: University of Glasgow
Conditions Psychosis
Enrollment 3,000 participants
Start Date 2022-04-20
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-11-29